1+1 is greater than 2 !
Based on the latest clinical progress, the bispecific antibody platform of EXCYTE, which combins two unique monoclonal antibody into one, has been tested as a novel molecule to realize the activity ef
Based on the latest clinical progress, the bispecific antibody platform of EXCYTE, which combins two unique monoclonal antibody into one, has been tested as a novel molecule to realize the activity ef